Cogent Biosciences, Inc. Quarterly Costs and Expenses in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cogent Biosciences, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2017 to Q3 2024.
  • Cogent Biosciences, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $75.4M, a 26.6% increase year-over-year.
  • Cogent Biosciences, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $260M, a 34.5% increase year-over-year.
  • Cogent Biosciences, Inc. annual Costs and Expenses for 2023 was $208M, a 40.8% increase from 2022.
  • Cogent Biosciences, Inc. annual Costs and Expenses for 2022 was $148M, a 95.7% increase from 2021.
  • Cogent Biosciences, Inc. annual Costs and Expenses for 2021 was $75.6M, a 16.1% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $260M $75.4M +$15.8M +26.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $245M $64.4M +$17.3M +36.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $227M $62.4M +$19.2M +44.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $208M $58.2M +$14.5M +33.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $194M $59.6M +$22.8M +61.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $171M $47.1M +$11.2M +31.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $160M $43.2M +$11.8M +37.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $148M $43.7M +$18.1M +70.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $130M $36.8M +$17M +85.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $113M $35.9M +$18.6M +107% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $94.2M $31.4M +$18.6M +145% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $75.6M $25.6M +$14.2M +124% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $61.4M $19.8M -$37.7M -65.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $99.1M $17.3M +$9.36M +118% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $89.7M $12.8M -$372K -2.82% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $90.1M $11.5M -$1.59M -12.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $91.7M $57.5M +$44.5M +340% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $47.2M $7.93M -$5.75M -42% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $53M $13.2M -$1.72M -11.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $54.7M $13M +$239K +1.87% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 $54.4M $13.1M +$437K +3.46% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $54M $13.7M +$2.57M +23.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $51.4M $14.9M +$5.69M +61.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $45.7M $12.8M +$3.81M +42.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 $41.9M $12.6M +$3.12M +32.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $38.8M $11.1M +$2.99M +36.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $35.8M $9.21M +$1.31M +16.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 $34.5M $9M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 $9.5M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $8.11M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $7.9M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.